Structure via PubChem · Public domain (PubChem)
pyrazolam
Sign in to savePyrazolam (SH-I-04) is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s. It has since been "rediscovered" and sold as a designer drug since 2012.
Chemical data
- Formula
- C16H12BrN5
- Molecular weight
- 354.2 g/mol
- IUPAC name
- 8-bromo-1-methyl-6-pyridin-2-yl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
- SMILES
- CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=N4
- InChIKey
- BGRWSFIQQPVEML-UHFFFAOYSA-N
- XLogP
- 1.4
- Polar surface area
- 56 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 353.028
Show 3 more facts
- chemical formula
- C₁₆H₁₂BrN₅
- canonical SMILES
- CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=N4
- Commons category
- Pyrazolam
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
6 sectionsContents
- Legal status
- United Kingdom
- United States
- Synthesis
- See also
- References
Pyrazolam (SH-I-04) is a benzodiazepine derivative originally developed by a team led by Leo Sternbach at Hoffman-La Roche in the 1970s. It has since been "rediscovered" and sold as a designer drug since 2012.
Pyrazolam has structural similarities to alprazolam and bromazolam. Unlike other benzodiazepines, pyrazolam does not appear to undergo metabolism, instead being excreted unchanged in the urine.
Excerpted from Wikipedia’s “pyrazolam” article, available under the CC BY-SA 4.0 licence.